Effects of Zidovudine on Pregnant Rats
Author Information
Author(s): James T. Christmas, Bertis B. Little, Kraig A. Knoll, Roger E. Bawdon, Larry C. Gilstrap III
Primary Institution: University of Texas Southwestern Medical Center
Hypothesis
Does zidovudine have teratogenic and embryocidal effects on postimplantation embryos in rats?
Conclusion
Zidovudine exposure during embryogenesis significantly increased pregnancy losses in rats, particularly at high doses.
Supporting Evidence
- High-dose zidovudine (150 mg/kg/day) led to significantly more pregnancy resorptions compared to controls.
- Four major structural anomalies were noted, but zidovudine was not linked to an increased frequency of congenital anomalies.
- The study involved 90 pregnant rats divided into five groups receiving different doses of zidovudine.
Takeaway
This study found that giving pregnant rats a drug called zidovudine can cause more babies to be lost, especially when given in high amounts.
Methodology
Pregnant Sprague-Dawley rats were given different doses of zidovudine or saline, and their fetuses were examined after sacrifice.
Limitations
The study's findings may not directly apply to humans due to species differences in teratogenicity.
Participant Demographics
Virgin female Sprague-Dawley rats were used in the study.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website